), aids to elucidate why KIF15 is ready to aid resistance to Eg5 inhibitors in vivo. MT gliding powered by both of those of those mitotic motors was arrested only every time they have been independently inhibited, lending help into the proposal that a combination drug therapy focusing on these motor